洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

首页 临床进展 SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW

【ChiCTR2100044537】SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW

查看原文
立即下载
基本信息
登记号

ChiCTR2100044537

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-03-23

临床申请受理号

/

靶点

/

适应症

Trauma

试验通俗题目

SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW

试验专业题目

SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

To describe the demographics (Age, Gender, Population group) of patients presenting to the Trauma Unit. To describe the mechanism of injury (blunt/penetrating) of patients presenting to the Trauma Unit and their relationship to SI. To describe the distribution of anatomical regions and initial physiological parameters of injuries in terms of Injury Severity scores. To evaluate the relationship between the SI and need for emergent surgical intervention To describe the type of emergent surgical intervention performed. To describe the relationship between SI and in-hospital mortality.

试验分类
试验类型

连续入组

试验分期

回顾性研究

随机化

N/A

盲法

N/A

试验项目经费来源

Private

试验范围

/

目标入组人数

1523

实际入组人数

/

第一例入组时间

2018-11-01

试验终止时间

2021-02-01

是否属于一致性

/

入选标准

All records of patients over the age of 18 years old who were trauma team activations；

排除标准

Patients declared Dead on Arrival or whose injuries are deemed non-survivable; All isolated Traumatic Brain Injury (TBI) patients and Isolated Thermal/Chemical Injuries; All patients taken for surgery for isolated Orthopaedic procedures where by the procedure is not related to the control of haemorrhage; Patients whose physiological response to hypovolemia will be altered such as those known to be on rate control medications / pace makers or started on inotropes prior to hospital admission; Patients referred in from another hospital; Patients discharged / who sign refusal of hospital treatment or abscond without admission to the unit for further treatment.；

研究者信息
研究负责人姓名
试验机构

Dr Richard Allan Crawford

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

Dr Richard Allan Crawford的其他临床试验

更多

南非约翰内斯堡University of Witwatersrand的其他临床试验

更多

最新临床资讯

更多
对摩熵医药数据库感兴趣，可以免费体验产品
体验产品